Recent studies show that androgen-induced apoptosis in Atlantic croaker primary granulosa and theca (G/T) cells and in human breast and prostate cancer cell lines is mediated by the membrane androgen receptor ZIP9, which belongs to the SLC39A zinc transporter family. However, the apoptotic signaling pathways remain unclear because ZIP9 activates an inhibitory G protein in human cancer cells, whereas recombinant croaker ZIP9 activates a stimulatory G protein (G s ) in transfected cancer cells. We investigated androgen-dependent apoptotic pathways to identify the signaling pathways regulated through wild-type croaker ZIP9 in ovarian follicle cells. We show that the ZIP9-mediated apoptotic signaling pathway in croaker G/T cells shares several proapoptotic members with those in human cancer cells, but is activated through a G s a subunit-dependent pathway. Testosterone treatment of croaker G/T cells increased intracellular zinc levels, mitogen-activated protein (MAP) kinase activity, caspase 3 activity, messenger RNA levels of proapoptotic members Bax, p53, and c-Jun N-terminal kinase, and the incidence of apoptosis, similar to findings in mammalian cancer cells, but also increased cyclic adenosine monophosphate concentrations. Transfection with small interfering RNA targeting croaker ZIP9 blocked testosterone-induced increase in bax, p53, and jnk expression. Testosterone-induced apoptosis and caspase 3 activation depended on the presence of extracellular zinc and were effectively blocked with cotreatment of inhibitors of the G s a subunit, adenylyl cyclase, protein kinase A, and MAP kinase (Erk1/2) activation. These results indicate that ZIP9-mediated testosterone signaling in croaker G/T cells involves multiple pathways, some of which differ from those activated through ZIP9 in human cancer cells even though a similar apoptotic response is observed. (Endocrinology 158: 3015-3029, 2017) A ndrogens regulate important ovarian processes in vertebrates, including folliculogenesis, proliferation, and apoptosis (1-6), but the mechanisms controlling these functions are often unclear. Many actions of androgens are genomic and are regulated by the nuclear androgen receptor (nAR), a ligand-activated transcription factor belonging to the nuclear receptor superfamily (7, 8) . The nAR knockout models show increases in atretic and unhealthy ovarian follicles and reductions in the number of corpora lutea and in litter size (9, 10), demonstrating that the nAR plays an important role in ovarian physiology. In contrast, nongenomic androgen actions and the receptors that mediate them in vertebrate ovaries have received much less attention and remain poorly understood. Nevertheless, rapid, nongenomic androgen actions have been described in human and Atlantic croaker ovaries (11, 12) , and androgen-binding moieties have been identified on croaker ovarian plasma membranes with binding characteristics different from those of nARs (13, 14) . More recent evidence indicated
A ndrogens regulate important ovarian processes in vertebrates, including folliculogenesis, proliferation, and apoptosis (1) (2) (3) (4) (5) (6) , but the mechanisms controlling these functions are often unclear. Many actions of androgens are genomic and are regulated by the nuclear androgen receptor (nAR), a ligand-activated transcription factor belonging to the nuclear receptor superfamily (7, 8) . The nAR knockout models show increases in atretic and unhealthy ovarian follicles and reductions in the number of corpora lutea and in litter size (9, 10) , demonstrating that the nAR plays an important role in ovarian physiology. In contrast, nongenomic androgen actions and the receptors that mediate them in vertebrate ovaries have received much less attention and remain poorly understood. Nevertheless, rapid, nongenomic androgen actions have been described in human and Atlantic croaker ovaries (11, 12) , and androgen-binding moieties have been identified on croaker ovarian plasma membranes with binding characteristics different from those of nARs (13, 14) . More recent evidence indicated that androgens induce apoptosis in croaker granulosa and theca (G/T) cells by a cell surface-initiated mechanism that is not mimicked by the nAR agonist, mibolerone, which suggests this androgen action is mediated by a membrane AR unrelated to the nAR, although its identity remained unknown (15) .
The croaker ovarian membrane AR was subsequently cloned and identified as ZIP9, the sole member of the ZIP zinc transporter (SLC39A) subfamily I (16) . Experiments using small interfering RNA (siRNA) targeting this protein confirmed that ZIP9 is a membrane AR and the intermediary in testosterone-induced apoptosis in croaker G/T cells (16) . ZIP9 is the first membrane AR to be identified in vertebrates and is widely expressed in croaker and human tissues (16, 17) . Human ZIP9 mediates androgen-induced apoptosis in a variety of breast and prostate cancer cell lines (17) , which indicates that ZIP9 initiates a common response to testosterone in both croaker G/T primary cells and in human cancer cells. Apoptosis is thought to be the primary mechanism regulating ovarian follicle atresia in mammals and also has been observed in late-stage atretic follicles of teleosts (18) (19) (20) . Apoptosis also plays an important role in the regression of the corpus luteum in mammals and postovulatory follicles in teleosts (18) (19) (20) (21) (22) . ZIP9's high expression in croaker ovaries and its stimulation of apoptosis (16) suggest that the receptor may have an important role in ovarian remodeling by regulating follicle cell apoptosis during the breakdown of atretic and postovulatory follicles.
Although ZIP9 was first discovered in the croaker primary G/T cells, further characterization of the receptor was conducted with recombinant croaker ZIP9 in transfected SKBR3 (SKBR3-ZIP9) AR-null breast cancer cells (16) , and with wild-type and overexpressed human ZIP9 in several AR-null breast and prostate cancer cell lines (17) . Human ZIP9-dependent apoptosis has been well characterized in MDA-MB-468 breast cancer cells and in PC-3 prostate cancer cells overexpressing ZIP9, where it shows a dose-dependent, specific response to testosterone that is accompanied by increases in intracellular free zinc (17) . The finding that testosterone treatment increases caspase 3 activity and messenger RNA (mRNA) levels of the proapoptotic regulators p53, Bax, and c-Jun N-terminal kinase (JNK) as well as increased protein levels of caspase 3, Bax, and mitochondrial cytochrome C in these cells indicates a plausible intrinsic apoptotic pathway through which testosterone induces apoptosis and cell death in these cancer cells. Although testosterone also induces apoptosis and increases intracellular free zinc in croaker G/T cells, it is not known if it involves the same apoptotic regulators as those identified in the human cancer cell models.
Information on testosterone regulation of proapoptotic regulators in croaker G/T cells would indicate if ZIP9 mediates apoptosis through a common mechanism in different cell types.
The apoptosis mechanisms in croaker G/T and human cancer cells potentially could differ because recombinant croaker ZIP9 and human ZIP9 have been shown to activate different G proteins (16, 17) . In SKBR3-ZIP9 cells, croaker ZIP9 activates a stimulatory G protein (G s ), resulting in increased cyclic adenosine monophosphate (cAMP) levels (16) , whereas in MDA-MB-468 and PC-3-ZIP9 cell lines, human ZIP9 activates an inhibitory G protein (G i ) (17) . The consequences of these differences in G protein activation in these models on their ZIP9 signaling are unknown because the pathway initiated by croaker ZIP9 is still obscure. In MDA-MB-468 cells, testosterone treatment increased extracellular signalregulated kinase (ERK) activation, and cotreatment with an ERK inhibitor (PD98059) effectively blocked testosterone-induced upregulation of proapoptotic genes. On the other hand, a rapid progestin-induced increase in ERK activity associated with a reduction in the incidence of apoptosis mediated by the membrane progestin receptor mPRa was observed in croaker primary G/T cells (23) . ERK activity has not been examined in relation to ZIP9 signaling in G/T cells, so it is not known whether ERK is primarily associated with cell survival in these cells or if it may also be involved in the apoptotic response initiated by ZIP9, as observed with activation of mammalian ZIP9 in cancer cells.
Interestingly, ZIP9 is the only steroid receptor identified that is also a zinc transporter. Zinc is an essential trace element that has a critical role in numerous physiological functions including transcriptional regulation of many genes, as a cofactor for hundreds of enzymes, signal transduction and rapid calcium signaling (24, 25) , and apoptosis (26, 27) . Zinc homeostasis is essential for maintaining these physiological functions. Although zinc deficiency causes cell death (28) (29) (30) , a rise in intracellular free zinc may increase apoptosis (31, 32) . Intracellular free zinc levels are controlled by zinc transporters belonging to the ZnT and ZIP families. The ZIP zinc transporter (SLC39A) family transports zinc across membranes from extracellular and subcellular compartments into the cytosol (33) . Androgen activation of ZIP9 causes a rise in intracellular free zinc in all the cell models in which it has been examined to date (16, 17) . This increase in free zinc levels was found to be androgen specific in the human cancer lines (17) . Moreover, cotreatment with the membrane permeable zinc chelator N,N,N 0 ,N 0 -Tetrakis(2-pyridylmethyl)ethylenediamine inhibits testosterone-induced apoptosis in both SKBR3-ZIP9 and MDA-MB-468 cells (16, 17) . These results indicate that the increase in intracellular zinc is a critical component of the ZIP9-induced signaling pathway mediating apoptosis. However, the source of this increased intracellular free zinc and the role of extracellular zinc on ZIP9's apoptotic functions have not been examined in any of the cell models.
The goal of the current study, therefore, was to characterize androgen-induced apoptosis and its signaling pathways through wild-type croaker ZIP9 in primary G/T cells. The testosterone specificity of the apoptotic and zinc responses were examined and compared with those of the specific AR agonist mibolerone because the AR is also expressed in croaker G/T cells. The proapoptotic genes bax, p53, and jnk were cloned from croaker ovaries; their regulation by testosterone through ZIP9 in croaker G/T cells was assessed for comparison with the previous results with human ZIP9 in cancer cells. In addition, the involvement of multiple signaling pathways and caspase 3 were examined to compare the ZIP9-mediated responses between the croaker G/T and human cancer cell models. A research emphasis was placed on the potential role of signaling induced through activation of the G s a subunit in ZIP9-mediated apoptosis because this pathway is absent in the previously characterized human cancer cell models. Finally, the role of extracellular zinc in the induction of apoptosis through ZIP9 was investigated.
Materials and Methods

Chemicals and materials
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise stated. Testosterone, 17,20b,21-trihydroxy-4-pregnen-3-one (20b-S), estradiol-17b, and cortisol were purchased from Steraloids (Newport, RI). Mibolerone was a gift from the Upjohn Laboratories (Kalamazoo, MI). Bovine serum albumin (BSA)-conjugated steroids were dialyzed to remove any free steroid by incubation with 5 mg/mL charcoal and 0.5 mg/mL dextran at 55°C with gentle rotation for 30 minutes followed by removal of charcoal by two centrifugation cycles at 4600g for 20 minutes each. Antibodies were obtained or produced as described in Table 1 .
Animal care and tissue collection
Atlantic croaker were purchased from local bait shops in Port Aransas, Texas, and transferred to fish-holding facilities at the University of Texas Marine Science Institute. Fish were maintained in recirculating saltwater tanks (salinity 30 to 32 ppt), and fed commercial pellets. The photoperiod was adjusted to replicate the local summer and fall conditions (13 hours of light, 11 dark at 26°C in August; 11 hours of light, 13 dark at 22°C to 23°C in December) during gonadal recrudescence. Fish were acclimated to laboratory conditions for a minimum of 2 months before being used for G/T cell isolation. Female fish at the peak of the reproductive period (gonadosomatic index .12) with oocytes averaging greater than 440 mm in diameter were considered reproductively mature and used for experimentation. Fish were deeply anesthetized by immersion in a bath containing 20 mg/L MS-222 and humanely euthanized by rapid decapitation in accordance with procedures approved by the University of Texas Animal Care and Use Committee. Ovarian tissue was excised and placed in a calcium-and magnesium-free balanced saline solution (138 mM NaCl, 8.6 mM KCl, 1.62 mM Na 2 HPO 4 , 5 mM D-glucose, 15.8 mM HEPES, 1 mM EDTA, 100 mg/L streptomycin, and 60 mg/L penicillin; pH 7.4) for G/T cell isolation.
Primary G/T cell culture
Unlike for mammalian ovaries, reliable methods for the separation of pure G-and T-cell populations from fish ovaries have not been developed; consequently, a coculture system was used. Croaker G/T cells were isolated from ovarian fragments by enzymatic digestion with collagenase as previously described (34) . G/T cells were resuspended in Dulbecco's modified Eagle medium (DMEM) supplemented with 3% bovine calf serum. To prevent the possible conversion of testosterone and endogenous steroid production by G/T cells, 100 mM of the P450 side chain cleavage and aromatase inhibitor DL-Aminoglutethimide (Alfa Aesar, Ward Hill, MA) was added to all the culture media. In coculture conditions, granulosa cells predominate (approximately 60% to 90%) after 3 to 4 days of culturing when experiments are typically performed. For ZIP9 knockdown experiments, cells were switched to antibiotic-free media and Membrane protein preparation G/T cells were harvested by adding cold (4°C) buffer (25 mM HEPES, 10 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, pH 7.6) containing protease inhibitor (1 mL/mL) to plates followed by scraping. All following steps were carried out at 4°C. Cells were rinsed two to three times and the buffer removed by centrifugation at 1000g. Cell pellets were then resuspended and cells lysed by sonication for 4 seconds. The sample was centrifuged at 1000g for 7 minutes to pellet the nuclear fractions. The supernatant containing membrane protein fraction was removed, placed into clean tubes, and centrifuged at 20,000g for 20 minutes to pellet the membrane protein fraction. The resulting pellet was resuspended in HEPES, NaCl, EDTA, and dithiothreitol buffer and 4X reducing sample buffer was added before boiling for 10 minutes. The samples were stored at 280°C until protein detection by Western blot analysis.
Western blot analysis
Electrophoresis was performed on membrane or whole cell lysate protein samples loaded on a 10% sodium dodecyl sulfatepolyacrylamide gel. Protein samples were transferred to a nitrocellulose membrane and blocked with 5% nonfat milk for 1 hour. After blocking, the membrane was incubated with the first antibody (ZIP9, 1:5000 [Research Resource Identifier (RRID): AB_2651045]; actin, 1:2000 (RRID: AB_11232819); p-Erk1/2, 1:1000 (RRID: AB_331768); t-Erk1/2, 1:1000 (RRID: AB_330744)) overnight at 4°C. The croaker ZIP9 primary polyclonal antibody was generated in mice against a partially purified ovarian membrane fraction with AR activity and validated for measurement in this species as described previously (16) After incubation, the membranes were washed three times followed by incubation with the secondary antibody (horseradish peroxidase-linked mouse or rabbit 1:2000; LI-COR mouse 1:5000) for 1 hour. Protein bands were visualized using Odyssey IR imaging system (LI-COR, Lincoln, NE) or using SuperSignal chemiluminescent substrate (Thermo Scientific, Grand Island, NY).
Hoechst apoptosis analysis
G/T cells were grown for 1 to 2 days on round, 15-mm glass coverslips placed in 12-well culture plates, serum-starved for 16 to 24 hours, and then incubated with the experimental treatments in serum-free DMEM (zinc: 1.5 mM) for 16 hours. At the end of the incubation, cells were fixed with 4% paraformaldehyde for 20 minutes. Cells were stained with 1 mg/mL Hoechst 33342 for 1 to 5 minutes, rinsed with phosphatebuffered saline (NaCl 137 mM, KCl 2.7 mM, Na 2 HPO 4 10 mM, KH 2 PO 4 1.8 mM), and mounted face down on microscope slides. Apoptotic cells were identified based on the morphology of chromatin under epifluorescent microscopy. Apoptotic nuclei in 400 cells from two to three replicates of each treatment were counted and expressed as the percent apoptotic cells. Zinc-free DMEM base (Sigma-Aldrich) media alone or with added zinc sulfate (1.5 mM) was used to investigate the effects of external zinc on the apoptosis response. Cells were washed once and incubated in the base media for 3 hours before the beginning of the experiment. Each experiment was repeated at least three times.
Intracellular zinc assay
G/T cells were grown in 96-well plates for one to two days until confluent. Cells were serum starved for 30 minutes followed by treatment with various steroids for 30 minutes. Cells were then fixed with 4% paraformaldehyde for 25 minutes at 4°C, stained with 10 mM zinquin ethyl ester (Enzo Life Sciences, Inc., Farmingdale, NY) for 30 minutes, washed, and immediately analyzed with fluorescence plate reader (excitation 368 nm, emission 490 nm). Results are expressed as the relative intensity of the zinc signals compared with the vehicle controls. Each treatment was replicated in 8 to 16 wells and repeated with cells from at least three fish.
Inhibitor treatments
Cells were pretreated with inhibitors of caspase 3 (10 mM, Z-DEVD-FMK), caspase 8 (10 mM, ZIETD-FMC), and Bax (50 mM, peptide V5) for 1 hour before cotreatment with testosterone. Likewise, specific inhibitors of the G s a subunit (NF449, Cayman Chemicals, Ann Arbor, MI), adenylyl cyclase [2', 5 0 -dideoxyadenosine (dd-Ado)], protein kinase A (KT5720; Biomol, Plymouth, MA), and ERK (PD98059; Biomol) were used to pretreat cells for 1 hour before cotreatment with testosterone.
cAMP assay cAMP was measured in cell lysates using a cAMP EIA kit (Cayman Chemicals). After isolation, G/T cells were cultured overnight, followed by serum starvation for 48 to 72 hours. Cells were treated for 10 minutes with vehicle or testosterone, washed twice with ice-cold phosphate-buffered saline, and lysed by 20 minutes' incubation with 100 mL 0.1 M HCl (12-well plate) on ice followed by scraping and repeated pipetting (203) to homogenize the suspension. The suspension was centrifuged at 1000g for 10 minutes and the supernatant was diluted two to three times and either assayed immediately or stored at 280°C. Data were normalized and presented as relative cAMP concentration
Caspase 3 activity
Cells were treated as in the Hoechst apoptosis assay, harvested, and caspase 3 activity was determined using a CaspaseGlo 3/7 Assay kit (Promega, Madison, WI) according to the manufacturer's instructions. Briefly, after treatment cells were scraped, lysed by sonication, and the supernatant was added to a 1:1 volume of Caspase-Glo reagent. The luminescence of each sample was immediately analyzed by a plate reader, and subsequent readings were taken every 3 minutes. The highest luminescence value obtained for each sample was used and expressed relative to vehicle control values. Each experiment was repeated at least three times.
ERK activation assay
G/T cells grown in 12-well plates were serum starved for 48 to 72 hours before a 15-minute treatment with testosterone, epidermal growth factor (100 nM; positive control), or vehicle.
Cells were harvested on ice using RIPA buffer (EMD Millipore, Billerica, MA) containing phosphatase and protease inhibitors, and the lysates were centrifuged at 15,000g for 5 minutes to remove insoluble material. Reducing sample buffer was added, the samples were boiled for 10 minutes, and then stored at 280°C until used for Western blot analysis. Total ERK and phosphorylated ERK were detected by primary antibodies directed at total p42/44 and phospho-p42/44 (Cell Signaling Technology Inc.). Horseradish peroxidase-conjugated secondary antibodies were detected with SuperSignal chemiluminescent substrate.
Cloning and sequencing of croaker bax, p53, and jnk complementary DNAs
Total RNA was harvested from G/T cells using TRI Reagent (Sigma-Aldrich) following the manufacturer's protocol. An RNase-free DNase kit (Promega) was used to remove any genomic DNA contamination. Complementary DNA (cDNA) was synthesized using SuperScript II reverse transcription (Invitrogen), and polymerase chain reaction (PCR) was performed using GoTaq Green Master Mix (Promega). Partial sequences of bax, p53, and jnk were initially obtained using degenerate primers. Degenerate oligonucleotide primers were designed from sequence alignments with highly conserved regions of closely related teleost species and used to amplify fragments of the croaker genes bax, p53, and jnk. Amplified PCR products of the expected size were resolved using 1% agarose gels, after which they were purified using the Wizard SV Gel and PCR Clean-Up System (Promega). Gene-specific primers were designed from the partial cDNA fragments obtained for each gene to amplify the 5 0 -and 3 0 -ends of each gene using the FirstChoice RLM-RACE Kit (Ambion, Austin, TX) to obtain the complete cDNA sequences for bax, p53, and jnk. The amplified cDNA fragments were subcloned with pGEM-T TAcloning plasmids (Promega) and sequenced at the University of Texas at Austin DNA Sequencing Facility. Nucleotide and amino acid homology were checked using BLAST (http://www. ncbi.nlm.nih.gov/BLAST/).
Quantitative real-time reverse transcription-PCR analysis
G/T cells were starved for 16 to 24 hours before treatment with ethanol vehicle, mibolerone (100 nM), or testosterone (100 nM) for the indicated time (4 to 48 hours), followed by RNA isolation and analysis. Quantitative real-time PCR (qPCR) primers were designed against the cloned sequences of bax, p53, and jnk (Supplemental Table 1 ). qPCR was performed using Verso 1-step reverse transcription-qPCR SYBR Green Low ROX kit (Thermo Scientific), 15 mL reaction volume with 100 ng of RNA per reaction, following the manufacturer's protocol. The qPCR program was set to 50°C for 15 minutes, 95°C 15 minutes, and 40 cycles of 95°C for 15 seconds, 55°C for 30 seconds, and 72°C for 30 seconds. Amplification was followed by the melting curve program, 95°C for 15 seconds, 60°C for 15 seconds, and a gradual increase to 95°C over 20 minutes. Samples were run in duplicates and expression of target genes was normalized to the housekeeping gene 18S.
Statistical analysis
All experiments were repeated at least three times with G/T cells from different fish. Statistical significance was 
Results
Characterization of testosterone-induced apoptotic response
Testosterone treatment increased G/T cell apoptosis in a concentration-dependent manner, with concentrations 10 nM and higher resulting in substantial increases compared with the vehicle control [ Fig. 1(a) ]. Treatment of G/T cells with 100 nM estradiol (E 2 ), cortisol, and the maturation inducing steroid in croaker 17, 20b, 21-trihydroxy-4-pregnen-3-one (20b-S) (35) for 16 hours had no effect on apoptosis, which suggests the apoptotic response is specific to androgens [ Fig. 1(b) ]. Apoptosis was not increased by treatment with the nAR agonist, mibolerone (100 nM), which suggests the proapoptotic action of testosterone is not mediated through the nAR [ Fig. 1(c) ]. The male androgen, 11-ketotestosterone, also had no effect of G/T cell apoptosis [ Fig. 1(c) ]. Treatment with the 5-alpha reductase inhibitor finasteride (50 mM) did not affect testosterone-induced apoptosis (Supplemental Fig. 1A) , which suggests that the apoptotic response is specific to testosterone and not a result of the conversion of testosterone to DHT. Treatment with 100 nM testosterone conjugated to BSA (T-BSA) also resulted in a substantial increase in G/T cell apoptosis compared with vehicle control, whereas treatment with E 2 -BSA had no effect, similar to that seen with E 2 (Supplemental Fig. 1B and Fig. 1C) .
Characterization of the intracellular free zinc
Testosterone treatment of 30 minutes caused a substantial increase in intracellular free zinc over the concentration range of 10 to 50 nM, but the response was not concentration-dependent [ Fig. 2(a) ]. Intracellular free zinc levels in G/T cells were unaltered compared with vehicle controls after 30 minutes of treatment with 100 nM mibolerone and nonandrogen steroids, whereas they were significantly increased after treatment with 100 nM testosterone, indicating the steroid specificity of the effect [ Fig. 2(b) ]. T-BSA treatment also resulted in an increase in intracellular free zinc concentrations, indicating that this response is mediated at the cell surface [ Fig. 2(c) ]. 
Role of caspases in testosterone-induced apoptosis
Cells were treated with selective inhibitors of caspase 3 (10 mM, Z-DEVD-FMK) and caspase 8 (10 mM, ZIETD-FMC) to identify which caspases may be involved in the testosterone-induced apoptotic pathway in G/T cells. Cotreatment with the caspase 3 inhibitor, but not the caspase 8 inhibitor, abolished testosterone-induced apoptosis [ Fig. 3(a) and 3(b) ]. Furthermore, testosterone (100 nM) treatment of 16 hours caused a substantial increase in caspase 3 activity [ Fig. 3(c) ].
Role of a Gsa subunit pathway in testosteroneinduced apoptosis
Treatment of G/T cells with either testosterone or T-BSA (50 nM) for 10 minutes resulted in a substantial increase in intracellular cAMP levels [ Fig. 4(a) ], indicating that testosterone induces a rise in cAMP levels through a cell surface-mediated mechanism. The role of downstream members of the Gsa subunit-mediated pathway in testosterone-induced apoptosis and caspase 3 activity was investigated using specific inhibitors of activation of the Gsa subunit (10 mM, NF449), adenylyl cyclase (50 mM, dd-Ado), and protein kinase A (PKA; 1 mM, KT5720). Cotreatment with the inhibitors blocked the testosterone-induced apoptosis and increase in caspase 3 activity, whereas treatment with the inhibitors alone did not alter apoptosis and caspase 3 activity [ Fig. 4(b) and Fig. 4(c) ].
Role of ERK signaling in testosterone-induced apoptosis
Phosphorylation of ERK was increased after incubation of G/T cells with testosterone (100 nM) for 15 minutes [ Fig. 5(a) ]. The ERK inhibitor PD98056 did not alter apoptosis or caspase 3 activity of G/T cells when administered alone, but cotreatment of the inhibitor and testosterone effectively inhibited testosterone induction of apoptosis and caspase 3 activity [ Fig. 5(b) and Fig. 5(c) ].
Cloning
Degenerate oligonucleotide primers were used to amplify fragments of the croaker genes bax, p53, and jnk. Gene-specific primers were designed from the cDNA partial fragments obtained from each gene, with which expected band lengths and sequences were confirmed by PCR, gel electrophoresis, and cloning (Supplemental No substantial interactive effects of testosterone treatment in the presence of the inhibitor on G/T cell apoptosis was detected by two-way ANOVA, which was predicted because the inhibitor had no effect on the androgen-induced response. ANOVAs for (a) and (b) were followed by Bonferroni multiple comparison test. Different letters indicate significant differences between different treatment groups in the post hoc test at P , 0.05. (c) Relative caspase 3 activity after 16-hour testosterone treatment. Results for (c) were analyzed with Student t test. **P , 0.01. All The deduced amino acid sequence shows high identities with Bax polypeptide sequences of other vertebrate species, including channel catfish (80%), zebrafish (76%), mouse (54%), and human (52%). Three evolutionarily conserved domains of the Bcl-2 family associated with Bax (BH1-3) were identified within the sequence. The complete alignment, as well as the conserved domains, is shown in Supplemental Fig. 3 . The full-length cDNA of croaker p53 was cloned and sequenced and has an ORF of 1080 nucleotides (GenBank no. KY435615), encoding a polypeptide of 360 amino acid residues. The deduced amino acid sequence shows high identities with p53 polypeptide sequences of other vertebrate species, including olive flounder (74%), European flounder (71%), puffer fish (69%), tilapia (66%), and human (46%). The complete alignment of the full-length amino acid sequence, along with five phylogenetically conserved domains of the p53 protein, is shown in Supplemental Fig. 4 . Two sequences were identified for croaker jnk cDNA, one with an ORF of 1260 nucleotides (GenBank no. KY435616), encoding a polypeptide of 420 amino acid residues (jnk1), and another with an ORF of 1062 nucleotides, encoding a polypeptide of 354 amino acid residues (jnk2). Croaker jnk1 shows high identities with JNK polypeptide sequences of other vertebrate species, including zebrafish (90%), goldfish (76%), human (76%), and swamp eel (74%). Croaker jnk2 shows the same sequence identity as jnk1, with the exception of a 66 amino acid deletion at position 235. The complete alignment of the two sequences is shown in Supplemental Fig. 5 .
Role of proapoptotic members
The role of Bax in the testosterone-induction of apoptosis was investigated using a selective inhibitor of the protein (50 mM, peptide V5). Cotreatment with the Bax inhibitor abolished testosterone-induced apoptosis [ Fig. 6[a) ]. The effect of testosterone treatment on the regulation of proapoptotic members Bax, p53, and JNK was determined by qPCR. bax mRNA expression in cells treated with vehicle, testosterone (100 nM) or mibolerone (100 nM) was measured at 48 hours. Testosterone treatment resulted in a substantial increase in bax expression compared with vehicle, but mibolerone treatment showed no effect [ Fig. 6(b) ]. A 24-hour treatment with 50 nM testosterone resulted in upregulation of expression of bax, p53, and jnk transcripts [ Fig. 6(c)] . A time-course experiment showed that bax expression is upregulated after 16 hours of treatment with 100 nM testosterone (Supplemental Fig. 6 ).
Role of ZIP9 in testosterone-induced proapoptotic gene expression, apoptosis, and cAMP response siRNA was used to knock down the expression of ZIP9 to determine whether upregulation of the proapoptotic genes, apoptosis, and the testosterone-induced cAMP response is mediated by ZIP9. ZIP9 knockdown completely abrogated the effect of 24-hour testosterone treatment on bax, p53, and jnk mRNA expression, whereas scrambled primers did not abolish the testosterone effect [ Fig. 7(a-c) ]. ZIP9 siRNA treatment also blocked the apoptotic response to testosterone, as measured by Hoechst assay [ Fig. 7(d) ]. Transfection with ZIP9 siRNA also abolished the testosterone-induced increase in cAMP levels, whereas scrambled primers were ineffective [ Fig. 7(e) ]. ZIP9 siRNA transfection resulted in a decrease in ZIP9 protein expression, whereas transfection with scrambled primers did not affect ZIP9 levels [ Fig. 7(f) ].
Requirement of zinc in the culture media for testosterone-induced apoptosis
The absence of added zinc in the zinc-free culture media resulted in an abrogation of the typical testosterone response, resulting in no important difference between control and testosterone treatment in apoptosis as determined by the Hoechst assay [ Fig. 8(a) ]. The absence of supplemented extracellular zinc also resulted in the inhibition of the testosterone-induced increase in bax expression [ Fig. 8(b) ] and caspase 3 activity [ Fig. 8(c) ].
Discussion
This study provides an in-depth investigation of ZIP9's actions in primary G/T cells from the croaker model in which the receptor was first cloned. Here we demonstrate that in Atlantic croaker G/T cells, ZIP9 elicits testosterone induction of apoptosis through a mechanism involving a Gsa subunit-dependent signaling pathway, ERK signaling, and the proapoptotic members caspase 3, Bax, p53, and JNK. The finding that testosterone treatment increases caspase 3 activity but not caspase 8 activity is consistent with ZIP9 induction of apoptosis through an intrinsic pathway. Recombinant croaker ZIP9 has previously been shown to be coupled to a G s protein and mediate a testosterone-induced increase in cAMP levels in transfected SKBR3 cells (16) . However, the current data provide evidence for a role of a Gsa subunit-dependent pathway in ZIP9-mediated apoptosis. Interestingly, ZIP9-induced apoptosis involves activation of an Erk signaling pathway as well as upregulation of the same Significance was determined by one-or two-way ANOVA with Bonferroni multiple comparison posttest. Different letters indicate significant differences between different treatment groups in the post hoc test at P , 0.05. In (b) and (c), substantial interactive effects of testosterone treatment in the presence of the inhibitor on G/T cell apoptosis and caspase 3 activity was detected by the two-way ANOVA, which was predicted because the inhibitor blocked these androgen-induced responses. All data represent means 6 SEM. All experiments were repeated with three to five fish and each treatment conducted in duplicate or triplicate with similar results obtained for each. EGF, epidermal growth factor; PD, PD98059 (10 mM).
proapoptotic members in G/T cells as observed in human breast and prostate cancer cell lines in which ZIP9 induces apoptosis through activation of a G i protein (17) . These findings suggest that the ZIP9-induced apoptosis in vertebrate cells can be regulated through different signal transduction pathways. Finally, the observation that the absence of supplemented zinc in the culture media blocked downstream testosterone-induced apoptotic events indicates that both the G s a signaling and zinc transport functions of ZIP9 are required for testosterone-induced apoptosis in G/T cells. The discovery that the ZIP9-mediated response requires the presence of supplemented extracellular zinc supports the role of ZIP9 concurrently acting as a membrane steroid receptor and as a zinc transporter.
Although it is perhaps surprising that a similar downstream apoptotic mechanism is induced by ZIP9 in diverse cell types through activation of different G proteins, the ability of ZIP9 to activate multiple G proteins is not unusual and has been reported with other hormone receptors (36, 37) . For example, membrane progesterone receptor alpha induces the resumption of meiosis through activation of an inhibitory G protein in croaker oocytes, whereas it causes sperm hypermotility in this species through activation of a stimulatory G olf protein (36) . ZIP9 has also been shown to interact directly with the G protein Gna11, which is a member of the Gqa protein family, in the murine spermatogenic GC-2 cell line (38) , which further supports the notion that ZIP9 can couple to a variety of different G proteins, and therefore activate different signaling pathways to modulate cell functions. It remains unknown if these differences in ZIP9 activation of a particular G protein are a reflection of the different cell models examined, or species differences, or a combination of both. Further studies on G protein coupling of ZIP9 in multiple cell types within a species and the same cell types in different species would clarify the basis for ZIP9 coupling to different G proteins.
The results show that the testosterone-induced increases in caspase 3 activity and apoptosis in croaker G/T cells are regulated by multiple signaling pathway components, involving activation of the G s a protein subunit, membrane adenylyl cyclase, PKA, and mitogenactivated protein (MAP) kinase. Whereas it is well accepted that activation of the membrane adenylyl cyclase/ cAMP/PKA pathway is mediated through the Ga subunit of the G s protein, the signal transduction mechanism resulting in increased MAP kinase/ERK activity remains unclear. Simultaneous activation of multiple signaling pathways through both the G protein a and bg subunits is commonly observed with G protein-coupled receptors (39) . Signaling through the bg subunit of the G protein is a potential mechanism of ERK activation in G/T cells because ERK can be activated through the bg subunits of both G i and G s proteins (40) . A common mechanism of ERK activation through the G protein bg subunits would provide a plausible explanation of how ERK is activated through ZIP9 in both croaker G/T cells and human cancer cells. Alternatively, ERK can be activated downstream of PKA (41), and thus the G s a-subunit could be primarily involved in activation of both signaling pathways in croaker G/T cells.
The involvement of cAMP in G/T cell apoptosis in croaker has previously been documented in granulosa cells isolated from rat preovulatory follicles (42, 43) , human ovum (44) , and in immortalized human granulosa cells (45) , which suggests that the induction of granulosa cell apoptosis through cAMP-dependent signaling is a common mechanism in vertebrate ovaries. There are no reports, to our knowledge, that testosterone treatment elevates cAMP concentrations in granulosa cells. However, androgens have been shown to increase cAMP levels in other tissues, although apoptosis was not examined in these studies (46, 47) . Many of the cAMP-related apoptotic responses in mammalian granulosa cells involve activation of the same proapoptotic members as those observed in the ZIP9-mediated G/T and cancer cell models, including p53 (43, 45, 48) and Bax (43) . The presence of ZIP9 in human ovaries and in an immortalized rat granulosa cell line (17) suggests it also has a physiological function in mammalian granulosa cells. A Figure 7 . Effect of ZIP9-targeting siRNA on mRNA expression of proapoptotic members, apoptosis, and cAMP levels. (a-f) Effects of ZIP9-targeting siRNA on the testosterone-induced increase in (a) bax, (b) p53, (c) jnk expression, (d) apoptosis, (e) cAMP levels, and (f) relative ZIP9 protein expression. All qPCR data were normalized to housekeeping gene 18S. In (a-e), significant interactive effects of each steroid treatment (veh, T) and the transfection treatments on proapoptotic member mRNA expression, G/T cell apoptosis, and cAMP was detected by the two-way ANOVA, which was predicted because ZIP9-targeting siRNA blocked the androgen-induced responses. *P , 0.05; **P , 0.01; ***P , 0.001 compared with control in Student t test. In (f), significance was determined by one-way ANOVA followed by with Bonferroni multiple comparison posttest. Different letters indicate significant differences between different treatment groups in post hoc test at P , 0.05. All data represent means 6 SEM. For gene expression and apoptosis experiments, steroid treatments were conducted in duplicate and repeated with five fish with similar results obtained for each. For cAMP experiment steroid treatments were conducted in triplicate with three fish with similar results obtained for each. actin, actin loading control; SC, scramble siRNA control.
major question under investigation is whether the same pathway activated by the ZIP9-coupled Gsa subunit in androgen induction of apoptosis of croaker G/T cells is activated by ZIP9 in mammalian ovarian follicle cells.
Members of the ZIP family of zinc transporters transport zinc into the cytoplasmic compartment, either from the extracellular region or intracellular compartments (33, 49) . ZIP9 is no exception, as demonstrated in earlier siRNA experiments in croaker G/T, MDA-MB-468, and ZIP9-transfected SKBR3 and PC-3 cells, in which ZIP9 expression was required for the increase in intracellular free zinc levels in response to testosterone treatments (16, 17) . However, the ZIP9 zinc response differs from those reported to date for all the other members of the ZIP family in that is induced by a steroid hormone, testosterone. The present results show the highly specific zinc response to testosterone in G/T cells is very similar to that reported for human ZIP9 in MDA-MB-468 cells (17) . The finding that the induction of apoptosis in the G/T cells shows the same steroid specificity is consistent with the hypothesis that the rise in intracellular free zinc is required for the testosterone-mediated apoptotic response. Previous results showing that chelation of internal zinc with N,N,N 0 ,N 0 -Tetrakis(2-pyridylmethyl) ethylenediamine in croaker ZIP9-transfected SKBR3 cells blocked testosterone-induced apoptosis further support this proposed role of zinc (16) . The present results provide evidence that extracellular zinc is required for testosterone upregulation of proapoptotic members and the completion of the apoptotic response through ZIP9. The testosterone-induced increase in apoptosis, intracellular free zinc concentrations, and cAMP levels in croaker G/T cells is mimicked by T-BSA, which cannot enter the cells and activate intracellular ARs. These actions of testosterone initiated at the cell surface further suggest the transport of extracellular zinc across the plasma membrane into the cell is the primary mechanism through which testosterone causes increases in intracellular free zinc concentrations. ZIP9 is primarily localized on the cell membranes of croaker G/ T cells and SKBR3-ZIP9 cells, but is found in multiple cellular fractions, including the mitochondrial, membrane, and nuclear fractions of MDA-MB-468 and ZIP9-transfected PC-3 cells (17) , and was reported to be confined to the trans-Golgi network in the chicken pre-B-cell line DT40 (50) . Therefore, it cannot be inferred from the current experiments that the testosterone-induced increase in intracellular free zinc is solely a result of ZIP9 importing extracellular zinc into the cell. Additional research on the movement of zinc between cellular compartments will be required to clarify the actions of zinc in ZIP9-mediated apoptosis. Figure 8 . Effect of extracellular zinc in testosterone-mediated apoptotic events. Testosterone induction of (a) apoptosis, (b) bax expression upregulation, and (c) caspase 3 activity when the testosterone treatment was administered in media supplemented with 1.5 mM or 0 mM zinc. Substantial interactive effects of testosterone at different zinc concentrations on G/T cell apoptosis, bax expression, and caspase 3 activity was detected by two-way ANOVA, which was predicted because the low zinc concentrations blocked these androgen-induced responses. All data represent means 6 SEM. Different letters indicate significant differences between different treatment groups in the Bonferroni multiple comparison posttest at P , 0.05. All experiments were repeated with three fish and each treatment was conducted in duplicate or triplicate with similar results obtained for each.
Mibolerone was used as a negative control in the current studies to differentiate androgen actions mediated through ZIP9, which does not bind mibolerone (16) , from those regulated by the nAR, which is expressed in croaker ovaries and displays a high binding affinity for this nAR agonist (14) . The finding that mibolerone does not cause increases in intracellular free zinc and apoptosis is consistent with previous results with nAR siRNA, indicating a lack of involvement of this receptor in androgen-induced G/T cell apoptosis (16) . Androgens have been reported to stimulate follicle growth, granulosa cell proliferation, and inhibit apoptosis in some studies (1-3), whereas others have shown a proapoptotic effect of androgen treatment on porcine and rat granulosa cells (5, 6, 51) . Murine nAR knockout models exhibit decreased follicle growth and increases in apoptosis and atresia within the ovary (9, 10, 52) . This suggests that the nuclear receptor likely plays an important role in murine folliculogenesis but not in the mediation of testosteroneinduced apoptotic events. Differential activation of nuclear and membrane ARs present in granulosa cells under different physiological conditions could partially explain the disparate effects of testosterone in the ovary, especially because different effects of androgens acting through intracellular and membrane ARs have been reported in C6 glial cells (53) .
ZIP9 regulation of ovarian follicle cell apoptosis may be particularly important for maintenance of ovarian physiology in teleost fishes such as croaker, which release thousands of eggs during each spawn and require extensive gonadal reconstruction following oocyte release. After teleosts spawn, apoptosis is required for follicular atresia and in the breakdown of the numerous postovulatory follicles (19) (20) (21) (22) . In contrast, apoptosis occurs during follicle attrition in the prenatal period and in atresia throughout life in mammals, but only a relatively small number of ovarian follicles undergo this process at any given time, which may explain, at least partially, the relatively low expression of ZIP9 in human ovaries (17) . Information on the expression of ZIP9 and its promotion of apoptosis in granulosa cells at different stages of follicular development in both teleosts and mammals will be required for a better understanding of ZIP9's role in teleost and mammalian ovarian physiology.
Based on the results presented here and prior findings (16), we propose a model for ZIP9 mediation of testosterone-induced apoptosis in croaker G/T cells through an intrinsic apoptotic pathway (Fig. 9 ). In this model, testosterone binds to ZIP9 on the cell surface to elicit an apoptotic pathway involving increased mRNA expression of proapoptotic genes and caspase 3 activity and a higher incidence of apoptosis. ZIP9 mediates these Figure 9 . Proposed model of testosterone (T) acting through ZIP9 to mediate croaker G/T cell apoptosis. ZIP9 is coupled to a stimulatory G protein, which leads to increased cAMP levels and MAP kinase activity, which, along with intracellular free zinc, are required for the induction of apoptosis. Further details of the model are described in the discussion. as, stimulatory G protein a-subunit; bg, G protein bg-subunit; Cyto C, cytochrome c; C3, caspase 3; PM, plasma membrane.
responses by activating a stimulatory G protein, which results in increased levels of cAMP and MAP kinase activity. Both MAP kinase and members of the G s a/ adenylyl cyclase/cAMP/PKA pathway are required for testosterone-mediated caspase 3 activation and apoptosis. In addition, supplemented extracellular zinc is required for testosterone-mediated increases in proapoptotic gene expression, caspase 3 activity, and apoptosis. Moreover, chelation of intracellular free zinc inhibits testosterone-induced apoptosis. This apoptotic response involves increased expression of JNK and P53, both of which are known to regulate expression of Bcl-2 family members such as Bax. Additionally, JNK and Bax can modulate mitochondrial membrane permeability, leading to subsequent cytochrome c release (54, 55) . To date, we have shown that ZIP9 knockdown results in abrogation of testosterone-mediated rapid signaling events such as increases in intracellular free zinc and cAMP levels, as well as downstream changes in proapoptotic gene expression and apoptosis.
In summary, the present results show that testosterone activation of the membrane receptor ZIP9 results in G/T cell apoptosis through a mechanism involving G s a subunit signaling and activation of the ERK signaling pathway. The activation of multiple pathways in the croaker G/T cell model suggests that ZIP9-mediated apoptosis is tightly controlled, and inhibition of any one of the numerous members of the pathway may control the shift between cell survival and cell death. The mechanism of action of ZIP9 through a G s protein in croaker G/T cells differs from that previously examined in human cancer cell lines (17) . The requirement of extracellular zinc for the completion of androgen-induced apoptotic events suggests that, in addition to acting as a membrane steroid receptor, ZIP9 also maintains zinc-transporter functions which are critical for its apoptotic functions. Although ZIP9's functions in ovarian physiology are not fully understood, that it induces G/T cell apoptosis suggests it likely has a role in follicular cell apoptosis during atresia and postovulatory follicle breakdown. The current study further characterizes a recently discovered mechanism by which steroid hormones can directly influence zinc homeostasis through a single protein, ZIP9. This mechanism coordinates androgeninduced G protein signaling pathways with zinc signaling to induce an essential cellular function, apoptosis, in vertebrate cells.
